Appendix 4E and 2025 Annual Report

Open PDF
Stock Cryosite Ltd (CTE.ASX)
Release Time 21 Aug 2025, 4:48 p.m.
Price Sensitive Yes
 Cryosite Reports Strong FY25 Results, Expands Ultra-Frozen Capacity
Key Points
  • Revenue up 12% to $14.1 million
  • EBITDA up 19% to $3.4 million
  • Ultra-Frozen and Cryogenic segment revenue grew 58%
  • Facility expansion completed, funded through cashflow
Full Summary

Cryosite Limited has reported a strong set of financial results for the year ended 30 June 2025, with revenue increasing by 12% to $14.1 million and EBITDA rising 19% to $3.4 million. The company's EBIT also grew by 22% to $2.5 million, despite a 160% increase in income tax expense following the full utilization of historical tax credits in the prior period. The Directors are pleased with the Group's operational performance, which reflects continued delivery against Cryosite's long-term strategy and sustained year-on-year momentum. The Ultra-Frozen and Cryogenic segment was a standout, with revenue increasing by 58% to $1.9 million and EBITDA growing 65% to $810,000. This was supported by capital investment, systems upgrades, and the onboarding of new clients and sponsors. Cryosite also completed a major expansion of its main facility in FY25, increasing the footprint by 17% and expanding its ultra-frozen and cryogenic temperature storage capacity. This project was fully funded through the company's strong cashflow position. The Directors are highly encouraged by the strong momentum demonstrated in the financial results and believe Cryosite is well-positioned for continued growth in the year ahead.